ID   T24/MMC
AC   CVCL_XX49
DR   cancercelllines; CVCL_XX49
DR   Wikidata; Q98133065
RX   CelloPub=CLPUB00543;
CC   Population: Caucasian; Swedish.
CC   Selected for resistance to: ChEBI; CHEBI:27504; Mitomycin C (MMC; MitC).
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 8
//
RX   CelloPub=CLPUB00543;
RA   Min Q., Cao S.-N., Gan Y.-P., Song T.-S., Liu F.-X., Ning Z.-F.;
RT   "Bladder cancer chemotherapy resistant cell harbors stem-like
RT   characteristics construction and characterization of T24 resistance
RT   strain of bladder cancer.";
RL   Clin. Oncol. J. 1:1004.09-1004.12(2019).
//